YU76500A - Hemijska sinzeza morfolinskih derivata - Google Patents

Hemijska sinzeza morfolinskih derivata

Info

Publication number
YU76500A
YU76500A YU76500A YU76500A YU76500A YU 76500 A YU76500 A YU 76500A YU 76500 A YU76500 A YU 76500A YU 76500 A YU76500 A YU 76500A YU 76500 A YU76500 A YU 76500A
Authority
YU
Yugoslavia
Prior art keywords
chemical synthesis
morpholine derivatives
derivatives
morpholine
mopholine
Prior art date
Application number
YU76500A
Other languages
English (en)
Inventor
Ian Frank Cottrell
Ulf H. Dolling
David Hands
Robert Darrin Wilson
Original Assignee
Merck Sharp & Dohme Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme Limited filed Critical Merck Sharp & Dohme Limited
Publication of YU76500A publication Critical patent/YU76500A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Predmetni pronalazak se odnosi na postupak za pripremanje morfolinskih derivata formule (I) koji su korisni kao terapijska sredstva.[The present invention relates to a process for the preparation of mopholine derivatives of formula (I) which are useful as a therapeutic agents.
YU76500A 1998-06-16 1999-06-10 Hemijska sinzeza morfolinskih derivata YU76500A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9813025.5A GB9813025D0 (en) 1998-06-16 1998-06-16 Chemical synthesis

Publications (1)

Publication Number Publication Date
YU76500A true YU76500A (sh) 2003-02-28

Family

ID=10833892

Family Applications (1)

Application Number Title Priority Date Filing Date
YU76500A YU76500A (sh) 1998-06-16 1999-06-10 Hemijska sinzeza morfolinskih derivata

Country Status (28)

Country Link
US (2) US6297376B1 (sh)
EP (1) EP1087966B1 (sh)
JP (2) JP4647783B2 (sh)
KR (1) KR100619589B1 (sh)
CN (1) CN1131864C (sh)
AR (1) AR018877A1 (sh)
AT (1) ATE217308T1 (sh)
AU (1) AU746721B2 (sh)
BR (1) BR9911250A (sh)
CA (1) CA2334821C (sh)
CZ (1) CZ299257B6 (sh)
DE (1) DE69901444T2 (sh)
DK (1) DK1087966T3 (sh)
EA (1) EA003468B1 (sh)
ES (1) ES2176036T3 (sh)
GB (1) GB9813025D0 (sh)
HR (1) HRP20000878B1 (sh)
HU (1) HUP0102867A3 (sh)
IL (2) IL139946A0 (sh)
NZ (1) NZ508558A (sh)
PL (1) PL196778B1 (sh)
PT (1) PT1087966E (sh)
SI (1) SI1087966T1 (sh)
SK (1) SK283380B6 (sh)
TW (1) TW526199B (sh)
UA (1) UA66866C2 (sh)
WO (1) WO1999065900A1 (sh)
YU (1) YU76500A (sh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030284A1 (es) 2000-06-08 2003-08-20 Merck & Co Inc Proceso para la sintesis de (2r, 2-alfa-r,3a) -2-[1-(3,5-bis(trifluorometil) fenil) etoxi]-3-(4-fluorofenil)-1,4-oxazina; dicho compuesto y sus formas polimorficas
GB0014876D0 (en) 2000-06-16 2000-08-09 Merck Sharp & Dohme Chemical synthesis
UA76810C2 (uk) 2001-12-10 2006-09-15 Мерк Енд Ко., Інк. Фармацевтична композиція антагоніста рецептора тахікініну у формі наночастинок
AR039625A1 (es) 2002-04-18 2005-03-02 Merck & Co Inc Proceso para la preparacion de 5-((2(r)--(1(r)- (3,5-bis (trifluormetil) fenil)etoxi-3 (s) - (4-fluorfenil) -4-morfolinil) metil) -1,2-dihidro-3h-1,2,4-triazol-3-ona
AU2003259866A1 (en) 2002-08-21 2004-03-11 Merck And Co., Inc. Process for preparing 3-chloromethyl-1,2,4-triazolin-5-one
US9227958B2 (en) 2006-02-03 2016-01-05 Glenmark Pharmaceuticals Limited Amorphous and crystalline forms of aprepitant and processes for the preparation thereof
WO2012146692A1 (en) 2011-04-29 2012-11-01 Sandoz Ag Novel intermediates for the preparation of highly pure aprepitant or fosaprepitant
ITMI20130273A1 (it) * 2013-02-26 2014-08-27 Olon Spa Procedimento per la preparazione di aprepitant
CN103288813A (zh) * 2013-06-04 2013-09-11 四川百利药业有限责任公司 一种阿瑞匹坦的制备方法
CN104628663A (zh) * 2013-11-08 2015-05-20 中山奕安泰医药科技有限公司 3-氯甲基-1,2,4-三唑啉-5-酮的合成方法
CN107698574B (zh) * 2017-11-23 2020-12-01 中山奕安泰医药科技有限公司 一种高纯度阿瑞匹坦的精制制备工艺
CN109485613B (zh) * 2018-11-21 2022-05-13 江苏慧聚药业股份有限公司 阿瑞匹坦和福沙匹坦边链片段的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111960A (en) 1993-12-17 1999-12-22 Merck & Co Inc Morpholines and thiomorpholines their preparation and pharmaceutical compositions containing them
BR9408442A (pt) 1993-12-29 1997-08-05 Merck Sharp & Dohme Composto composição farmacêutica processos para tratamento ou prevenção de distúrbios fisiológicos associados com um excesso de taquiquininas e para a preparação do composto e de uso do composto
TW385308B (en) * 1994-03-04 2000-03-21 Merck & Co Inc Prodrugs of morpholine tachykinin receptor antagonists
WO1995030674A1 (en) 1994-05-05 1995-11-16 Merck Sharp & Dohme Limited Morpholine derivatives and their use as antagonists of tachikinins

Also Published As

Publication number Publication date
CA2334821C (en) 2009-02-03
CN1305475A (zh) 2001-07-25
AU4281399A (en) 2000-01-05
NZ508558A (en) 2003-07-25
SK19212000A3 (sk) 2001-07-10
JP2002518388A (ja) 2002-06-25
EA003468B1 (ru) 2003-06-26
IL139946A (en) 2007-05-15
CN1131864C (zh) 2003-12-24
US20020019524A1 (en) 2002-02-14
HRP20000878B1 (en) 2009-09-30
AU746721B2 (en) 2002-05-02
PT1087966E (pt) 2002-10-31
JP5285652B2 (ja) 2013-09-11
KR20010052886A (ko) 2001-06-25
HUP0102867A2 (hu) 2002-05-29
TW526199B (en) 2003-04-01
ATE217308T1 (de) 2002-05-15
JP2010195808A (ja) 2010-09-09
CZ20004734A3 (cs) 2001-08-15
DE69901444T2 (de) 2002-11-28
GB9813025D0 (en) 1998-08-12
EP1087966B1 (en) 2002-05-08
CA2334821A1 (en) 1999-12-23
PL196778B1 (pl) 2008-01-31
US6407255B2 (en) 2002-06-18
EP1087966A1 (en) 2001-04-04
DK1087966T3 (da) 2002-07-08
HRP20000878A2 (en) 2001-12-31
US6297376B1 (en) 2001-10-02
SK283380B6 (sk) 2003-06-03
WO1999065900A1 (en) 1999-12-23
ES2176036T3 (es) 2002-11-16
UA66866C2 (uk) 2004-06-15
PL344581A1 (en) 2001-11-05
CZ299257B6 (cs) 2008-05-28
IL139946A0 (en) 2002-02-10
JP4647783B2 (ja) 2011-03-09
BR9911250A (pt) 2001-03-13
SI1087966T1 (en) 2002-10-31
DE69901444D1 (de) 2002-06-13
EA200100040A1 (ru) 2001-06-25
HUP0102867A3 (en) 2004-06-28
KR100619589B1 (ko) 2006-09-05
AR018877A1 (es) 2001-12-12

Similar Documents

Publication Publication Date Title
BG106340A (en) Substituted oxoazaheterocyclyl compounds
BG106585A (en) Kinase inhibitors as therapeutic agents
MY121760A (en) Benzothiazin and benzoxazin derivatives;their preparation and uses
NZ504106A (en) Fused Oxazine, Thiazine and pipyridine compounds, process for their preparation and pharmaceutical compositions containing them
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
MY120090A (en) Chemical compounds.
JO2654B1 (en) Multiple aryl caroxa amides are useful as lipid - lowering agents
DE60112330D1 (en) Pyrazolopyridinderivate
HK1019878A1 (en) Total synthesis of antitumor acylfulvenes.
ZA200404752B (en) 6-aminomorphinane derivatives method for the production and use thereof
YU76500A (sh) Hemijska sinzeza morfolinskih derivata
MXPA02009643A (es) Sintesis acortada de derivados de 3,3-diarilpropilamina.
YU75101A (sh) Supstituisani biciklični heterocikli, postupak njihove izrade i njihova upotreba kao antigojaznih i hipoholesterolemijskih agenasa
MXPA01008347A (es) Compuestos quimicos.
SI1102765T1 (en) PROCESS FOR THE SYNTHESIS OF (1$i(H))-BENZO C)QUINOLIZIN-3-ONES DERIVATIVES
UA72883C2 (uk) Біциклічна сполука, способи її одержання, фармацевтичні композиції, що її містять,способи лікування та попередження різних захворювань, проміжні сполуки та способи їх одержання
HU0004701D0 (sh)
ZA200005110B (en) Process for preparing intermediates.
ZA986680B (en) Thiazolobenzoheterocycles their preparation and medicaments containing them
MXPA04003085A (es) Proceso estereoespecifico para sintesis de derivados de 2-il cromano.
MY120806A (en) Improved process for preparing pharmaceutically valuable norbenzomorphane derivatives.
GB9924759D0 (en) Process for preparing peptide intermediates
MXPA04002784A (es) Sales farmaceuticamente aceptables de 20(s)-camptotecinas.
GB9516143D0 (en) Improved chemical synthesis
MX9603450A (es) Procedimiento para la obtencion de aminotriazolinas substituidas.